ReviewCurrent neuropharmacology2018
Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design.
Sheikh Arslan Sehgal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it